$CBIO News Article - Catalyst Biosciences Presents
Post# of 54
(Total Views: 253)
Posted On: 02/07/2020 11:35:42 AM
$CBIO News Article - Catalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD Congress https://marketwirenews.com/news-releases/cata...97010.html
(0)
(0)Gyre Therapeutics, Inc. (GYRE) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼